These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1741195)

  • 41. Infections of bones and joints in children.
    Fink CW; Dich VQ; Howard J; Nelson JD
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):578-83. PubMed ID: 263926
    [No Abstract]   [Full Text] [Related]  

  • 42. Pediatric Humeral Osteomyelitis.
    Street M; Crawford H
    J Pediatr Orthop; 2015 Sep; 35(6):628-33. PubMed ID: 25379820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of quinolones for the treatment of osteomyelitis and septic arthritis.
    Waldvogel FA
    Rev Infect Dis; 1989; 11 Suppl 5():S1259-63. PubMed ID: 2672253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
    LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
    Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective survey of acute osteoarticular infections in a French paediatric orthopedic surgery unit.
    Ferroni A; Al Khoury H; Dana C; Quesne G; Berche P; Glorion C; Péjin Z
    Clin Microbiol Infect; 2013 Sep; 19(9):822-8. PubMed ID: 23957786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children.
    Belthur MV; Phillips WA; Kaplan SL; Weinberg J
    J Pediatr Orthop; 2010 Dec; 30(8):942. PubMed ID: 21102227
    [No Abstract]   [Full Text] [Related]  

  • 47. [Oral pristinamycin therapy for bone and joint infections in children. A report of 50 cases (author's transl)].
    Beauvais P; Filipe G; Berniere J; Carlioz H
    Arch Fr Pediatr; 1981; 38(7):489-93. PubMed ID: 6793018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.
    Pääkkönen M; Kallio PE; Kallio MJ; Peltola H
    Pediatr Infect Dis J; 2012 May; 31(5):436-8. PubMed ID: 22189524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute osteomyelitis and septic arthritis in children.
    Coombes WN
    S Afr Med J; 1984 Jul; 66(2):46. PubMed ID: 6740423
    [No Abstract]   [Full Text] [Related]  

  • 50. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
    Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
    Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child.
    Williams B; Neth O; Shingadia D; Dixon G; Jupp RS; Rosendahl K; Eastwood D; Klein N; Brogan P
    Pediatr Infect Dis J; 2010 Jan; 29(1):88-9. PubMed ID: 19884872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety profile and efficacy of cefotaxime for the treatment of hospitalized children.
    Jacobs RF; Darville T; Parks JA; Enderlin G
    Clin Infect Dis; 1992 Jan; 14(1):56-65. PubMed ID: 1571464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic conundrum.
    Rosenberg NM; Vergara TM; Kleiner G; Schubert CJ; Kunkel NC
    Pediatr Emerg Care; 2000 Feb; 16(1):61-4. PubMed ID: 10698150
    [No Abstract]   [Full Text] [Related]  

  • 54. [Descriptive study of bone and joint infections in children in times of community-acquired methicillin- resistant Staphylococcus aureus (CA-MRSA)].
    Rosanova MT; Beberían G; Bologna R; Giménez S; Sarkis C; Buchovsky A; Pérez-M D G; Pinheiro J; Lede R
    Rev Chilena Infectol; 2015 Jun; 32(3):321-5. PubMed ID: 26230439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
    LeFrock J; Mader J; Smith B; Carr B
    Infection; 1985; 13 Suppl 1():S50-5. PubMed ID: 4055056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
    Nelson JD; Bucholz RW; Kusmiesz H; Shelton S
    J Pediatr Orthop; 1982 Aug; 2(3):255-62. PubMed ID: 7130382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefotaxime therapy for patients with osteomyelitis and septic arthritis.
    Mader JT; LeFrock JL; Hyams KC; Molavi A; Reinarz JA
    Rev Infect Dis; 1982; 4 Suppl():S472-80. PubMed ID: 6294801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outbreak of osteomyelitis/septic arthritis caused by Kingella kingae among child care center attendees.
    Kiang KM; Ogunmodede F; Juni BA; Boxrud DJ; Glennen A; Bartkus JM; Cebelinski EA; Harriman K; Koop S; Faville R; Danila R; Lynfield R
    Pediatrics; 2005 Aug; 116(2):e206-13. PubMed ID: 16024681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antibiotherapy in osteoarticular bacterial infections].
    Bensasson M; Lequesne M
    Rev Rhum Mal Osteoartic; 1973; 40(7):521-7. PubMed ID: 4756427
    [No Abstract]   [Full Text] [Related]  

  • 60. Antimicrobiol therapy: therapeutic recommendations and a review of newer drugs. Part I. Therapy of infectious conditions.
    McCracken GH; Eichenwald HF
    J Pediatr; 1974 Sep; 85(3):297-312. PubMed ID: 4610417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.